Equities

Zylox-Tonbridge Medical Technology Co Ltd

Zylox-Tonbridge Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)10.76
  • Today's Change-0.02 / -0.19%
  • Shares traded43.50k
  • 1 Year change-8.03%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Zylox-Tonbridge Medical Technology Co Ltd, formerly Zylox Medical Device Co Ltd, is a China-based company mainly engaged in the research and development of neurological and peripheral vascular interventional medical devices. The Company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The Company's products are sold to domestic and foreign markets.

  • Revenue in HKD (TTM)569.75m
  • Net income in HKD-85.00m
  • Incorporated2012
  • Employees765.00
  • Location
    Zylox-Tonbridge Medical Technology Co Ltd270 Shuyun RoadCangqian Street, Yuhang DistrictHANGZHOU ChinaCHN
  • Phone+86 57 188610082
  • Fax+86 57 188610608
  • Websitehttps://www.zyloxtb.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PW Medtech Group Ltd728.80m165.37m1.83bn1.24k11.080.41955.582.510.10560.10560.46552.790.13312.199.21585,854.604.047.234.918.0956.4258.1330.3785.3812.70--0.00024.1125.7516.7844.465.94-7.92--
MicroPort CardioFlow Medtech Corp362.97m-509.06m1.83bn592.00--0.7274--5.05-0.2154-0.21540.15361.040.12052.783.67613,123.30-16.91-17.37-18.11-22.962.06-1.67-140.25-180.829.91-11.560.0293--33.94---3.77---14.16--
Acotec Scientific Holdings Ltd511.55m15.64m1.96bn638.00120.541.4029.963.840.0520.0521.704.470.31360.72133.44801,808.800.9589--1.03--79.65--3.06--9.122.750.1529--19.80---79.35------
Venus MedTech HangZhou Inc530.47m-759.75m2.48bn865.00--0.7861--4.67-1.74-1.741.217.150.10140.94021.65613,264.20-15.04-13.20-17.41-14.9779.2179.51-148.37-152.831.86-8.780.2206--20.8933.6233.46--58.20--
OrbusNeich Medical Group Holdings Ltd1.20bn351.86m2.77bn1.25k7.900.96167.192.300.42260.42261.443.470.40431.344.38961,674.8011.84--12.86--69.22--29.29--8.60--0.0198--12.45--143.76------
China Isotope & Radiation Corp7.16bn400.49m3.42bn3.11k8.550.67553.160.47781.251.2522.3915.840.53124.221.842,306,913.006.216.5712.8213.2652.4859.8911.7012.621.73--0.191928.277.8215.35-5.432.883.632.89
Zylox-Tonbridge Medical Technolgy Co Ltd569.75m-85.00m3.58bn765.00--1.06--6.28-0.2587-0.25871.7310.150.15920.9991480.65744,770.60-2.38---2.56--72.95---14.92--4.88--0.018--57.97--30.66------
Yidu Tech Inc871.30m-210.46m3.64bn902.00--0.8388--4.18-0.2001-0.20010.82854.090.1658114.901.36965,962.60-4.54-35.96-5.35-51.3842.0634.80-27.41-159.716.77--0.0227--0.295351.2368.96------
Modern Dental Group Ltd3.17bn404.10m3.88bn7.04k9.661.487.091.220.42450.42453.332.780.84689.105.49450,895.3010.747.0512.608.3453.6150.7712.689.242.5313.170.243839.9812.086.5083.3036.462.42--
Microport NeuroTech Ltd-100.00bn-100.00bn4.56bn571.00------------------------------------------------21.61--768.73------
Shanghai Conant Optical Co Ltd1.90bn353.04m4.78bn2.51k13.533.1711.502.520.82760.82764.453.530.93282.166.48757,139.4017.3412.5722.4018.6937.4035.2718.5814.642.15--0.133518.5712.7015.5631.5633.0413.49--
Shanghai INT Medical Instruments Co Ltd812.74m168.91m4.89bn1.57k28.232.6622.576.020.98470.98474.7410.470.39042.227.75518,661.307.958.639.499.7658.1959.4420.3526.161.88--0.053531.8028.5029.9618.7921.7645.75--
AK Medical Holdings Ltd1.18bn196.59m4.96bn1.05k25.171.9216.834.200.17560.17561.062.300.37870.84062.381,122,533.006.309.277.5211.2861.6665.0616.6521.782.77--0.043122.653.9712.74-11.074.6721.675.88
Data as of Jul 26 2024. Currency figures normalised to Zylox-Tonbridge Medical Technology Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

25.06%Per cent of shares held by top holders
HolderShares% Held
Lake Bleu Capital (Hong Kong) Ltd.as of 30 Jun 202318.05m5.56%
AIHC Capital Management Ltd.as of 02 Jul 202416.35m5.04%
Snow Lake Management LPas of 17 Feb 202316.20m4.99%
Schroder Investment Management (Hong Kong) Ltd.as of 30 Oct 202316.19m4.99%
Fidelity Management & Research (Hong Kong) Ltd.as of 31 May 20245.78m1.78%
FIL Investment Management (Hong Kong) Ltd.as of 31 Mar 20241.93m0.60%
Schroder Investment Management Ltd.as of 30 Oct 20231.78m0.55%
Mediolanum International Funds Ltd.as of 29 Dec 20231.75m0.54%
Schroder Investment Management (Singapore) Ltd.as of 30 Oct 20231.74m0.54%
E Fund Management Co., Ltd.as of 31 Dec 20231.59m0.49%
More ▼
Data from 28 Sep 2023 - 02 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.